Optical in vivo analyte probe using embedded intradermal particles

• US 20050027176A1
• Filed: 08/02/2004
• Published: 02/03/2005
• Est. Priority Date: 07/31/2003
• Status: Abandoned Application

• Current Assignee: Marblia Ltd., Skymoon Research & Development, LLC
• Original Assignee: Skymoon Research & Development, LLC
• Inventors: Xie, Jinchun
• Application Number:
  US10/909,571
• Publication Number:
  US 20050027176A1
• Time in Patent Office: Days
• US Class Current: 600/316
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites

Abstract

A system and method of in vivo detection and quantification of one or more analytes. Small particles comprising a surface-active monolayer coating are embedded in the dermis. The surface-active monolayer acts to pre-concentrate the analyte by adsorbing the analyte from bulk solution. The concentrated analyte is more readily detected and quantified by one or more spectroscopic methods such as Raman spectroscopy

Claims

1. A method for in vivo detection of an analyte in a subject, comprising the steps of:

embedding sensitized particles within the skin of the subject, the sensitized particles having an adsorptive affinity for the analyte such that the analyte concentration at the surface of the sensitized particles is greater than the analyte concentration in the subject;

optically illuminating the sensitized particles with excitation radiation;

collecting and measuring optical radiation emitted by the sensitized particles; and

analyzing the emitted radiation to detect the analyte and/or quantify the concentration of the analyte in the subject.

2. The method of claim 1, where the particles comprise nanospheres coated with a silver film.

3. The method of claim 2, where the nanospheres are further coated with a self assembled monolayer which acts to preconcentrate said analyte.

4. The method of claim 1, where the emitted radiation comprises Raman scattered radiation.

5. The method of claim 4, where the Raman scattered radiation comprises surface enhanced Raman scattered radiation.

6. The method of claim 1, wherein the sensitized particles are embedded within the dermis layer of the subject'"'"'s skin.

7. The method of claim 1, wherein the sensitized particles are embedded in the skin of the subject'"'"'s inner arm.

8. The method of claim 7, wherein the particles are embedded within the skin of the subject'"'"'s inner wrist or the skin of the subject'"'"'s inner upper arm.

9. The method of claim 1, wherein the source radiation is a laser beam.

10. The method of claim 9, further comprising the step of aligning the laser beam to the particles using a means for visual alignment.

11. The method of claim 1, further comprising the steps of:

obtaining an analyte signal A at a first excitation wavelength;

obtaining a small particle background signal BG at a second excitation wavelength;

obtaining a baseline signal BS; and

calculated and correcting an analyte signal substantially equal to (A-BS)/(BG-BS).

12. The method of claim 1, wherein the analyte is glucose.

13. An apparatus for in vivo determination of an analyte, comprising:

a housing, the housing being attachable to a subject'"'"'s arm by a strap such that a face of the housing is approximately flush with a skin surface on the subject'"'"'s arm;

an optical path for conveying an incident beam of excitation light from an excitation source and for conveying collected scattered radiation to a detector;

the optical path comprising an angled mirror to direct the incident beam approximately perpendicular to the skin, and a focusing lens that focuses the incident beam on a tattoo spot in the skin and focuses the scattered radiation emitted from the tattoo spot.

14. The apparatus of claim 13, wherein the optical path further comprises:

a first optical fiber bundle conveying the incident beam to the housing;

the excitation source being external to the housing; and

a second optical fiber bundle conveying the scattered radiation to the detector, the detector being external to the housing.

15. The apparatus of claim 13, further comprising:

an eye viewing port for finding the tattoo spot and for properly aligning the incident beam, the eye viewing port further comprising an eye viewing port, the eye viewing port being mounted in the housing on a side of the housing opposite the face of the housing that lies flush with the skin such that the focusing lens, the angled mirrir, and the viewing port for a linear optical path to the skin.

16. The apparatus of claim 15, further comprising:

a cross-hair reticule for aligning the incident beam with the tattoo spot.

17. The apparatus of claim 15, wherein:

the angled mirror has a high reflection coefficient for near-infrared radiation and a near-100% transmission of visible light.

18. The apparatus of claim 13, wherein:

the incident light beam provides near-infrared excitation light.

19. The apparatus of claim 13, further comprising:

a window positioned in the face of the housing that mounts flush to the skin, the window having a refractive index that is substantially similar to that of the skin, the window providing a surface near the skin onto which a grease may be applied to reduce discontinuity in refractive index between the skin surface and the window.